At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
The Spanner Temporary Prostatic Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of The Spanner® Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men Unfit for Other Treatments
In Brief
A clinical study evaluating The Spanner Temporary Prostatic Stent for Urinary Retention. Completed, enrolled 107 participants across 6 sites.
Detailed Summary
The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Retention
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartAug 2016
Primary CompletionJan 2019
Study CompletionFeb 2019
TodayJul 2026
First PostedDec 31, 2015
Enrollment StartAug 1, 2016
Primary CompletionJan 1, 2019
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.5 years ago
Interventions
The Spanner Temporary Prostatic Stentdevice